Anti-CBLB antibody [EPR28082-32]
- 20ul selling size
- RabMAb
- KO Validated
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Knockout Tested Rabbit Recombinant Monoclonal CBLB antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 1 publication.
View Alternative Names
RNF56, Nbla00127, CBLB, E3 ubiquitin-protein ligase CBL-B, Casitas B-lineage lymphoma proto-oncogene b, RING finger protein 56, RING-type E3 ubiquitin transferase CBL-B, SH3-binding protein CBL-B, Signal transduction protein CBL-B
- WB
Supplier Data
Western blot - Anti-CBLB antibody [EPR28082-32] (AB315021)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The identity of the lower MW band at approximately 38 kDa is unknown.
The identity of the band higher than 250 kDa is unknown.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
All lanes:
Western blot - Anti-CBLB antibody [EPR28082-32] (ab315021) at 1/1000 dilution
Lane 1:
C6 (rat glial tumor glial cell) whole cell lysate at 20 µg
Lane 2:
Neuro-2a (mouse neuroblastoma neuroblast) whole cell lysate at 20 µg
Lane 3:
U-87 MG (human glioblastoma-astrocytoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
SH-SY5Y (human neuroblastoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 6:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 7:
PC-12 (rat adrenal gland pheochromocytoma cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 125 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-CBLB antibody [EPR28082-32] (AB315021)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, ab315021 was shown to bind specifically to CBLB. A band was observed at 125 kDa in wild-type Hela cell lysates with whereas no signal observed at this size in CBLB knockout cell line ab264711 (knockout cell lysate ab258342).
The identity of the band at 38 kDa is unknown.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-CBLB antibody [EPR28082-32] (ab315021) at 1/1000 dilution
Lane 1:
Wild-type HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CBLB knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-cblb-knockout-hela-cell-lysate-ab258342'>ab258342</a>) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 125 kDa,36 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-CBLB antibody [EPR28082-32] (AB315021)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The identity of the lower MW band at approximately 38 kDa is unknown.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
All lanes:
Western blot - Anti-CBLB antibody [EPR28082-32] (ab315021) at 1/1000 dilution
Lane 1:
Rat liver lysate at 20 µg
Lane 2:
Mouse liver lysate at 20 µg
Lane 3:
Mouse testis lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 125 kDa
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-CBLB antibody [EPR28082-32] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CBLB plays a critical role in immune regulation and is part of the ubiquitin-proteasome system. As a member of the CBL protein family it interacts with several other proteins to form a complex that determines its function. This complex mediates signal transduction and maintains immune homeostasis efforting its regulatory influence over immune cell activation and avoiding excessive immune responses.
Pathways
CBLB integrates into intracellular signaling involving the T-cell receptor (TCR) and B-cell receptor (BCR) pathways. It modulates downstream signaling by finetuning protein levels and activity interfacing with related proteins such as ZAP70 and Syk. By controlling signal thresholds it ensures proper immune responses and prevents autoimmunity maintaining the balance in signal transduction processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Journal of inflammation (London, England) 22:23 PubMed40537786
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com